15.39USD-3.57%Mkt Cap: 469.46M $P/E: —2d ago
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. Th…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap469.46M $
Enterprise Value497.94M $
Revenue (TTM)42.28M $
Gross Profit22.69M $
Net Income (TTM)-25.54M $
Revenue/Share1.445 USD
Last Price15.39 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees160
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-13.73
PEG0.61
EV/EBITDA-17.65
EV/Revenue11.78
P/S10.96
P/B43.03
EPS (TTM)-1.12
EPS (Forward)-1.11
52W Range
8.27033% of range30.10
52W High30.10 USD
52W Low8.270 USD
Profitability
Gross Margin61.38%
Oper. Margin-94.15%
EBITDA Margin-66.73%
Profit Margin-69.08%
ROE-91.15%
ROA-26.13%
Growth
Revenue Growth18.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.93M $
CapEx (TTM)522.00K $
FCF Margin-33.23%
FCF Yield-2.99%
Net Debt34.58M $
Net Debt/EBITDA-1.23
Balance Sheet
Debt/Equity2.08
Current Ratio4.75
Quick Ratio3.75
Book Value/Sh0.3530 USD
Cash/Share0.9630 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 27, 2016
Splits
Last Split1:40
Split DateJul 27, 2016
Analyst Consensus
Rating—
Target (Mean)25.67 USD
Upside (mean)+66.8%
Target Range22.00 USD – 30.00 USD
$22.00+66.8% to mean$30.00
# Analysts3
Ownership
Shares Out.30.50M
Float26.30M
Insiders5.44%
Institutions52.43%
Short Interest
Short Ratio7.4d
Short % Float13.21%
Short % Out.12.77%
Shares Short3.89M
Short (prev mo.)4.30M
Technical
SMA 5015.74 (-2.2%)
SMA 20013.50 (+14.0%)
Beta1.27
S&P 52W Chg18.16%
Avg Vol (30d)573.67K
Avg Vol (10d)439.50K
Technical Indicators
RSI (14)57.8
MACD0.0117
MACD Signal-0.2111
MACD Hist.+0.2228
BB Upper16.23 USD
BB Middle14.62 USD
BB Lower13.00 USD
BB Width22.05%
ATR (14)0.8329 USD
Vol Ratio (20d)0.83x